KEYWORD INDEX
 |
|
| Click on the first letter of the keyword: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other |
|
|
|
|
|
|
|
|
|
|
Search results for: "V"
Results 1 - 10 of 53 shown below |
|
|
|
|
|
|
|
| V1a receptor |
|
| Isadora F Bielsky, Shuang-Bao Hu, Kathleen L Szegda, Heiner Westphal and Larry J Young Profound Impairment in Social Recognition and Reduction in Anxiety-Like Behavior in Vasopressin V1a Receptor Knockout Mice doi:10.1038/sj.npp.1300360 Neuropsychopharmacology 29, 483-493 | Abstract | Full text | PDF | |
|
|
|
| V1b receptor |
|
| Jeanne Stemmelin, Ludovit Lukovic, Nicolas Salome and Guy Griebel Evidence that the Lateral Septum is Involved in the Antidepressant-Like Effects of the Vasopressin V1b Receptor Antagonist, SSR149415 doi:10.1038/sj.npp.1300562 Neuropsychopharmacology 30, 35-42 | Abstract | Full text | PDF | |
|
|
|
| vacuous chewing movements |
|
| Peter Turrone, Gary Remington, Shitij Kapur and José N Nobrega Differential Effects of Within-Day Continuous Vs Transient Dopamine D2 Receptor Occupancy in the Development of Vacuous Chewing Movements (VCMs) in Rats doi:10.1038/sj.npp.1300233 Neuropsychopharmacology 28, 1433-1439 | Abstract | Full text | PDF | |
|
|
|
| Vagal tone |
|
| David B Newlin, Conrad J Wong, June M Stapleton and Edythe D London Intravenous Cocaine Decreases Cardiac Vagal Tone, Vagal Index (Derived in Lorenz Space), and Heart Period Complexity (Approximate Entropy) in Cocaine Abusers doi:10.1016/S0893-133X(00)00135-4 Neuropsychopharmacology 23, 560-568 | Abstract | Full text | PDF | |
|
|
|
| Vagus nerve stimulation |
|
| Charles B Nemeroff, Helen S Mayberg, Scott E Krahl, James McNamara, Alan Frazer, Thomas R Henry, Mark S George, Dennis S Charney and Stephen K Brannan VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms doi:10.1038/sj.npp.1301082 Neuropsychopharmacology 31, 1345-1355 | Abstract | Full text | PDF | |
|
|
|
| Harold A Sackeim, A John Rush, Mark S George, Lauren B Marangell, Mustafa M Husain, Ziad Nahas, Christopher R Johnson, Stuart Seidman, Cole Giller, Stephen Haines, Richard K Simpson and Robert R Goodman Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome doi:10.1016/S0893-133X(01)00271-8 Neuropsychopharmacology 25, 713-728 | Abstract | Full text | PDF | |
|
|
|
| validation studies |
|
| Jean-François Etter, Jacques Le Houezec and Thomas V Perneger A Self-Administered Questionnaire to Measure Dependence on Cigarettes: The Cigarette Dependence Scale doi:10.1038/sj.npp.1300030 Neuropsychopharmacology 28, 359-370 | Abstract | Full text | PDF | |
|
|
|
| Valproate |
|
| Mara L Cordeiro, Cameron B Gundersen and Joy A Umbach Convergent Effects of Lithium and Valproate on the Expression of Proteins Associated with Large Dense Core Vesicles in NGF-differentiated PC12 Cells doi:10.1038/sj.npp.1300288 Neuropsychopharmacology 29, 39-44 | Abstract | Full text | PDF | |
|
|
|
| Karen T Hallam, James S Olver and Trevor R Norman Effect of Sodium Valproate on Nocturnal Melatonin Sensitivity to Light in Healthy Volunteers doi:10.1038/sj.npp.1300739 Neuropsychopharmacology 30, 1400-1404 | Abstract | Full text | PDF | |
|
|
|
| Mehmet E Dokucu, Liangping Yu and Paul H Taghert Lithium- and Valproate-Induced Alterations in Circadian Locomotor Behavior in Drosophila doi:10.1038/sj.npp.1300764 Neuropsychopharmacology 30, 2216-2224 | Abstract | Full text | PDF | |
|
|
|
| Robert Vadnal and Ranganathan Parthasarathy Myo-Inositol Monophosphatase: Diverse Effects of Lithium, Carbamazepine, and Valproate doi:10.1038/sj.npp.1380262 Neuropsychopharmacology 12, 277-285 | Abstract | PDF | |
|
|
|
| Robert M Post, Mark A Frye, Kirk D Denicoff, Gabriele S Leverich, Tim A Kimbrell and Robert T Dunn Beyond Lithium in the Treatment of Bipolar Illness doi:10.1016/S0893-133X(98)00020-7 Neuropsychopharmacology 19, 206-219 | Abstract | Full text | PDF | |
|
|
|
| Charles L Bowden New Concepts in Mood Stabilization: Evidence for the Effectiveness of Valproate and Lamotrigine doi:10.1016/S0893-133X(98)00025-6 Neuropsychopharmacology 19, 194-199 | Abstract | Full text | PDF | |
|
|
|
| Len V Hua, Marty Green, Adrienne Wong, Jerry J Warsh and Peter P Li Tetraspan Protein CD151: A Common Target of Mood Stabilizing Drugs? doi:10.1016/S0893-133X(01)00269-X Neuropsychopharmacology 25, 729-736 | Abstract | Full text | PDF | |
|
|
|
| Alan C Swann, Charles L Bowden, Joseph R Calabrese, Steven C Dilsaver and David D Morris Pattern of Response to Divalproex, Lithium, or Placebo in Four Naturalistic Subtypes of Mania doi:10.1016/S0893-133X(01)00390-6 Neuropsychopharmacology 26, 530-536 | Abstract | Full text | PDF | |
|
|
|
| Valproic acid |
|
| Laszlo Gyulai, Charles L Bowden, Susan L McElroy, Joseph R Calabrese, Frederick Petty, Alan C Swann, James C-Y Chou, Adel Wassef, Craig S Risch, Robert M A Hirschfeld, Charles B Nemeroff, Paul E Keck, Dwight L Evans and Patricia J Wozniak Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression doi:10.1038/sj.npp.1300190 Neuropsychopharmacology 28, 1374-1382 | Abstract | Full text | PDF | |
|
|
|
| Todd D Gould, Guang Chen and Husseini K Manji In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3 doi:10.1038/sj.npp.1300283 Neuropsychopharmacology 29, 32-38 | Abstract | Full text | PDF | |
|
|
|
Tomasz Schneider and Ryszard Przew ockiBehavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism doi:10.1038/sj.npp.1300518 Neuropsychopharmacology 30, 80-89 | Abstract | Full text | PDF | |
|
|
|
| Tomasz Schneider, Joanna Turczak and Ryszard Przewocki Environmental Enrichment Reverses Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Issues for a Therapeutic Approach in Autism doi:10.1038/sj.npp.1300767 Neuropsychopharmacology 31, 36-46 | Abstract | Full text | PDF | |
|
|
|
| Guang Chen, Husseini K Manji, Clinton B Wright, David B Hawver and William Z Potter Effects of Valproic Acid on  -adrenergic Receptors, G-proteins, and Adenylyl Cyclase in Rat C6 Glioma Cellsdoi:10.1016/0893-133X(95)00207-T Neuropsychopharmacology 15, 271-280 | Abstract | PDF | |
|
|
|
| Guang Chen, Peixiong Yuan, David B Hawver, William Z Potter and Husseini K Manji Increase in AP-1 Transcription Factor DNA Binding Activity by Valproic Acid doi:10.1016/S0893-133X(96)00239-4 Neuropsychopharmacology 16, 238-245 | Abstract | PDF | |
|
|
|
| Scott Alan Sands, Victoria Guerra and David Andrew Morilak Changes in Tyrosine Hydroxylase mRNA Expression in the Rat Locus Coeruleus Following Acute or Chronic Treatment with Valproic Acid doi:10.1016/S0893-133X(99)00072-X Neuropsychopharmacology 22, 27-35 | Abstract | Full text | PDF | |
|
|
|
| Steven C Stout, Michael J Owens, Kimberly P Lindsey, David L Knight and Charles B Nemeroff Effects of Sodium Valproate on Corticotropin-Releasing Factor Systems in Rat Brain doi:10.1016/S0893-133X(00)00243-8 Neuropsychopharmacology 24, 624-631 | Abstract | Full text | PDF | |
|
|
|
| vanilloid receptor |
|
| Leonora E Long, Daniel T Malone and David A Taylor Cannabidiol Reverses MK-801-Induced Disruption of Prepulse Inhibition in Mice doi:10.1038/sj.npp.1300838 Neuropsychopharmacology 31, 795-803 | Abstract | Full text | PDF | |
|
|
|
| Vascular dementia |
|
| S L Pimlott, M Piggott, J Owens, E Greally, J A Court, E Jaros, R H Perry, E K Perry and D Wyper Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380 doi:10.1038/sj.npp.1300302 Neuropsychopharmacology 29, 108-116 | Abstract | Full text | PDF | |
|
|
|
| Daniel P Holschneider, Andrew F Leuchter, Sebastian H J Uijtdehaage, Michelle Abrams and Susan Rosenberg-Thompson Loss of High-Frequency Brain Electrical Response to Thiopental Administration in Alzheimer's-Type Dementia doi:10.1016/S0893-133X(96)00220-5 Neuropsychopharmacology 16, 269-275 | Abstract | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | |
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
